Biodegradable drug-eluting coronary artery stent

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Commercializzato da:

Abbott Vascular Division of Abbott Medical Australia Pty Ltd

Classe:

Class I

Prodotto da:

Abbott Vascular 3200 Lakeside Drive, Santa Clara, CA, 95054 United States Of America

Area terapeutica:

56304 - Biodegradable drug-eluting coronary artery stent

Indicazioni terapeutiche:

The Absorb Bioresorbable Vascular Scaffold is a temporary scaffold indicated for improving coronary luminal diameter that will eventually resorb and potentially facilitate normalization of vessel function in patients with ischemic heart disease due to de novo native coronary artery lesions. The treated lesion length should be less than the nominal scaffolding length (8 mm, 12 mm, 18 mm, 23 mm, 28 mm) with reference vessel diameters (RVD) ? 2.5 mm and ? 3.75 mm.

Stato dell'autorizzazione:

A

Data dell'autorizzazione:

2017-07-06